Medtronic announced an international clinical trial comparing standard cardiac resynchronization therapy against CRT with the AdaptivCRT physiologic pacing algorithm that makes automatic adjustments to the therapy.
ReShape Medical revealed the first postapproval data from the EU for its nonsurgical, balloon-based weight-loss system: 42% of excess weight loss on average with a variance of 23%. But the company cautions that because of the different way the trials are designed, it won't have similar results when it releases pivotal U.S. trial data in November.
President Obama highlighted a $78.9 million BRAIN Initiative project to improve service members' and veterans' health through the development of nano-scale electrical implants to modulate nerve signaling and record health biomarkers.
Johnson & Johnson's DePuy Synthes unit is facing regulators' ire as the FDA slapped the company's recall of its jaw-stabilizing device with a Class I label, its most serious designation.
A novel biomarker could make it easier for physicians to diagnose rheumatoid arthritis early, thereby improving patients' prospects. The best results come when conventional antibody testing is combined with the new biomarker.
Medtronic wants to be known for manufacturing high-quality devices and providing related services as well. To that end, the company today announced the acquisition of privately held Italian company NGC Medical S.p.A.
Epilepsy devicemaker NeuroSigma filed to raise up to $50 million in an IPO, while ReWalk--whose mobile exoskeletons were recently approved by the FDA--set IPO terms to raise $50 million.
A competition three-and-a-half years in the making is nearing a finish to find the real-life diagnostic technologies that are closest to replicating the omnipresent tricorder health diagnostic device featured in the science-fiction television drama Star Trek.
Plastic surgeons in India were able to convert CT scans of a three-year-old girl suffering with craniosynostosis into a physical replica using a 3-D printer. The realistic, life-size model was then used in practice runs of the surgery.
A study of robotic laparoscopic radical prostatectomy found that though it is more expensive than traditional prostate removal surgery and technically more demanding, it is also associated with a quicker recovery of continence and shorter operating time.
Mobile medical app provider AirStrip reeled in $25 million in strategic capital to beef up its product offerings and develop its innovative health monitoring system for smartphones.
Philips is working to get its healthcare business back on track after a recent dismal quarter for the business and a management re-shuffle for it. Its latest missive is an emergency assistance app from the Philips Lifeline unit that gives seniors 24-hour access to emergency assistance.
Boston Scientific faces more than 23,000 lawsuits over its Pinnacle transvaginal mesh device. Last week it failed to remove four cases from a consolidated multidistrict litigation suit in the U.S. District Court for Western Virginia.
Researchers are developing an implantable sensor for glaucoma that allows intraocular pressure to be read by a smartphone camera. Diagnosis and monitoring now relies on a trip to the ophthalmologist and a reading of intraocular pressure that can vary widely. The implant/smartphone combination is expected to allow at-home monitoring and a series of readings that could improve diagnosis and monitoring of glaucoma patients.
When the heart is at risk, patients are eager to listen to their doctor's recommendations. But three studies have found that many cardiologists oversell the benefits of percutaneous coronary interventions involving stenting, and patients often fail to remember the doctor's precautions about the procedure.
Medtronic today announced the $200 million acquisition of the Netherlands' Sapiens Steering Brain Stimulation to bulk up its neuromodulation offerings.
Medtronic snagged FDA approval for its next-generation cardiac resynchronization therapy (CRT) pacemaker in patients with heart failure, expanding its cardiovascular portfolio and advancing its proprietary technology for heart rhythm therapy.
Scientists from three Boston institutions have created CellNet, a computer algorithm to assist scientists in their efforts to engineer specialized cells.
Biovigil Hygiene Technologies has developed a device that detects when a medical professional enters a patient's room and subsequently issues an alert if the doctor did not wash their hands after patient care.
Endo Health Solutions is shopping its medical device unit American Medical Systems. The Minnetonka, MN-based company was recently in the news for settling many of its vaginal mesh-related lawsuits, and has caught the attention of private-equity firms and other health care companies.